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Abstract
Background: Gastrointestinal complaints are very common in the general population and very often co-occur with
common mental disorders. We aimed to study the prospective impact of gastrointestinal complaints on long term
sickness absence, and address the contribution from co-occurring common mental disorders and other somatic
symptoms.
Method: Health data on 13 880 40-45 year olds from the Hordaland Health Study (1997-99) were linked to
national registries on sickness absence. As part of a wider health screening, gastrointestinal complaints were
ascertained. Participant’s anxiety and depression, and the presence of other somatic symptoms were evaluated. In
Cox regression models, we predicted sickness absences over an average 5.4 years follow-up, with adjustment for
confounders, anxiety and depression and other somatic symptoms.
Results: After adjusting for gender, level of education and smoking, those reporting GI complaints had higher risk
for later sickness absence (HR = 1.42, 95% CI 1.34-1.51). GI complaints were associated with both anxiety (OR =
3.66, 95% CI 3.31-4.04) and depression (OR = 3.28, 95% CI 2.89-3.72), and a high level of other somatic symptoms
(OR = 8.50, 95% CI 7.69-9.40). The association of GI complaints was still independently associated with future
sickness absence (HR = 1.17, 95% CI 1.10-1.16) adjusting for mental illness and other somatic symptoms.
Discussion: Sickness absence is a complex behavioural outcome, but our results suggest GI complaints contribute
by increasing the risk of long term sickness absence independently of comorbid mental illness and presence of
other somatic symptoms. Occupational consequences of illness are important, and should also be addressed
clinically with patients presenting with GI complaints.
Keywords: Sickness absence, gastrointestinal complaints, anxiety, depression
Background
Gastrointestinal (GI) complaints are very common in
the general population, with, for example, more than
half the sample of a large US-based study reporting
such complaints in the previous three months [1]. In a
Norwegian general population sample, 48% reported
having had at least one GI complaint during the pre-
vious year [2]. Such complaints may be symptoms of
distinct underlying organic pathology, but in many cases
no clear explanation is found [3-7]. People with GI com-
plaints, regardless of whether there is an underlying
pathology, have a number of negative psychosocial
sequelae, including a poorer quality of life [8,9] and
increased health care utilisation [9-12]. These features
are shared with somatic symptoms in general: They are
very common [13,14], can often occur without a clear
medical explanation [15], and are associated with dis-
tress and disability.
A major psychosocial consequence of illness across
the OECD-member countries is the increasing propor-
tions of the work force absent from work for longer
periods of time. This leads to increased benefit expen-
diture, reduced productivity and tax income from the
societal view and reduced income, loss of role and
esteem for the individual [16]. Compared to the major
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absence [17] the lack of quality studies on the causes
of sickness absence is striking [18], with few studies
addressing this topic amongst people with GI com-
plaints. Drossman and colleagues found that persons
w i t hG Ic o m p l a i n t ss u c ha sf u n ctional gastrointestinal
disorder reported a higher number of days off work
per year than the population free of such disorders [1].
A few other studies also provide indications for an
association between GI complaints and self-reported
sickness absence [19,20], but a recent Swedish study,
found no such association between functional gastroin-
testinal disorders and sickness absences recorded in
patient journals [21]. Only one study has evaluated this
prospectively; a recent US study found that patients
with functional dyspepsia had more short and long
sickness absences than controls [22].
A number of cross sectional general population stu-
dies have reported strong associations between gastroin-
testinal complaints and both common mental disorders
such as anxiety and depression [2,23-27] and general
symptom reporting [28-30]. Mussel et al recently found
that about one in five GI-patients in primary care also
satisfy criteria for anxiety and depression [31], and a
meta-analysis suggested that anxiety and depression are
more common in people with both functional and veri-
fied gastrointestinal disorders than healthy controls [32].
As common mental disorders and somatic symptom
reporting across organ systems are strong predictors for
later awards of disability pension [33], any observed
associations between GI complaints and sickness
absence reported above may therefore be explained by
these confounders. Further “lifestyle-factors” such as
physical activity [34], smoking [35], alcohol use [36] and
obesity [27,37] have all been linked to GI complaints
and chronic physical illnesses. As these same factors
also might relate to functional outcomes like sickness
absence, they could explain parts of any association
between GI complaints and sickness absence.
Given that the risk for permanent work force exit
increases when sickness absence is long lasting [38]
much policy is focussed upon those with long term sick-
ness group. Efforts are being made to identify both high
risk groups for this outcome and selected or indicated
interventions to prevent it. Although there is a sugges-
tion that people with GI complaints may be an impor-
tant group to identify clinically the current literature on
consequences of GI complaints seems to leave some
important questions unanswered: Does reporting a high
level of GI complaints at baseline predict long term
sickness absences? If so, is it accounted for by one or
more particular GI complaint? And, if such a predictive
relationship is found, is it explained (in part or fully) by
associated comorbidities or confounders measured at
baseline?
Methods
We conducted an historical cohort study employing data
from a large population based health survey, linked to
national registries of medically certified sickness absence
benefits awarded up to 6.1 years after the baseline health
survey.
Population and data material
The Hordaland Health Study 1997-1999 (HUSK) was a
joint epidemiological research project carried out by the
National (Norwegian) Health Screening Service in colla-
b o r a t i o nw i t ht h eU n i v e r s i t yo fB e r g e n .T h eb a s ep o p u -
lation included 29 400 individuals in Hordaland County
in western Norway born 1953-57, aged 40-47 at the
time of the data collection. Data were collected using
two sets of questionnaires and clinical examinations. A
total of 18 581 (8 598 men and 9 983 women) both
answered the first questionnaire and came to the clinical
examinations, yielding an initial participation rate of
63% (57% for men and 70% for women).
We excluded another 2 646 cases who did not return
or complete needed items on the second questionnaire
(administered at the clinical examination to be filled out
and returned later), and another 1 875 who did not
report being in paid work at baseline. A further 164
were excluded as their first short sickness absence per-
iod after health survey participation led directly to
award of a permanent disability pension e.g. in the case
of certain terminal or catastrophic illness. This left a
final sample of 13 880 (approximately 47% of the base
population).
Exposure: Gastrointestinal complaints
In the first questionnaire participants were asked if
they experienced each of six common gastrointestinal
(GI) complaints ("stomach pain”, “nausea”, “feeling
bloated”, “coated tongue”, “vomiting or regurgitation”
and “frequent loose bowel movements”,e x t r a c t e df r o m
the ICD-10 research criteria for F45-Somatoform dis-
orders [39]), “almost never”, “rarely”, “sometimes”,
“often”,o r“almost always”,s c o r e d0 - 4 .F o rt h em a i n
analysis, we were interested in identifying people who
reported a high level of gastrointestinal complaints;
We therefore summed each participant’st o t a ls c o r e
across the 6 GI items, and as the distribution was
highly skewed, we constructed a dichotomy with the
80
th percentile as cut off (high level of GI complaints).
To examine if the risk of sickness absence was con-
fined to specific complaints, we constructed another
set of variables where a response to each of the six
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coded as 1, and less often as 0.
Anxiety and depression
Anxiety and depression were assessed with the Hospital
Anxiety and Depression Scale (HADS), which contain
seven items each on cognitive symptoms of anxiety dis-
order and depression (HADS) [40]. In a recent literature
review, HADS showed good case-finding properties for
anxiety and depression in primary care patient popula-
tions [41]. A cut-off score of ≥8 on each subscale was
found to give the optimal balance between sensitivity
and specificity (both about 0.8) for depression and anxi-
ety according to DSM-III and IV, or ICD-8 and -9 [41],
and was therefore was therefore used as cut-off.
Other somatic symptoms
The participants were also asked if they experienced
each of the following 11 symptoms “almost never”,
“rarely”, “sometimes”, “often” or “almost always” (0-4):
chest pain, breathlessness, dysuria, unpleasant sensations
in or around the genitals, complaints of blotchiness or
discolouration of the skin, unpleasant numbness or tin-
gling sensations, joint or muscle pain (all derived from
the ICD-10 research criteria for F45 - Somatoform dis-
orders [39]), sore or running eyes or nose, headache,
dizziness, fatigue. In line with identifying those with
high GI complaints levels we constructed another vari-
able identifying a general high level of somatic symp-
toms by summing these scores and dichotomised at the
80
th percentile.
Physical conditions
Physical conditions were assessed through self-report in
the form: “d oy o uh a v eo rh a v ey o uh a da n yo ft h ef o l -
lowing”, followed by a list of ten conditions: coronary
infarction, angina, stroke, asthma, diabetes, multiple
sclerosis, hay-fever, chronic bronchitis, osteoporosis or
fibromyalgia. From previous studies it was clear that the
prevalence of these conditions in this middle aged
working population was low. We therefore dichoto-
mised this into those with no conditions “0”, and those
with one or more conditions “1”. Weight and height
was measured by research nurses, and BMI categorised
as normal (BMI < 24.9), overweight (BMI 25-29.9) and
obese (BMI 30+).
Demographics and health behaviours
The highest education level reported was recoded into
four categories: “elementary schooling”, “upper second-
ary school”, “1-3 years of higher education” and “higher
education exceeding four years”. Information on age and
gender was provided by the national population registry
prior to invitation and inclusion in the health survey.
Alcohol usage, assessed through self reported consump-
tion of beer, wine and spirits over the past two-week
period was categorised as abstinence, or low, medium
and high consumption defined according to gender spe-
cific tertiles. Physical activity was measured through two
variables on intense and light physical activity. These
were combined into one variable reflecting “no”, “mod-
erate” and “high levels of physical activity”. Smoking sta-
tus was defined as daily smoker vs. other.
Outcome: Sickness absence
Information on sickness absence awarded until end of
2003 was collected from the Norwegian National Insur-
ance Administration, and merged with the HUSK data
by Statistics Norway using national personal identifica-
tion numbers. In Norway, the employers cover the first
16 days of a sickness absence (first 14 days until April
1998). After this, the National Insurance Scheme covers
absences up to a total of 52 weeks. As a consequence,
the official registries (which are used in the present
study) do not include information on absences shorter
than 16 (or previously 14) days. Further in the Norwe-
gian system, a 56-day consecutive sickness absence
prompts a thorough medical report including an activity
plan for the patient’s return to work. After 12 weeks,
the national insurance scheme requires an extended
plan and meetings towards the same purpose, which
falls close to the previously used definition of long-term
sickness absence of 90 consecutive days [42]. We there-
fore registered the first incident sickness absence from
17 days after the health survey participation, and used
the start-stop dates to constructed the following
mutually exclusive variable s :i )T h ef i r s tL T S A( L o n g
Term Sickness Absence) lasting from 17-55 consecutive
days during follow-up, ii) The first LTSA lasting from
56-89 consecutive days during follow-up, and iii) The
first LTSA lasting for more than 90 consecutive days
during follow-up. As contrast for all these variables
were those with no LTSA during follow-up.
Statistical analysis
Descriptive statistics were reported as means and fre-
quencies. We then examined if there were significant
differences in the distribution of the potential confound-
ing variables between participants with and without GI
complaints, and those with or without sickness absence
during the follow up period using independent sample
t-tests for continuous variables and chi-square statistics
for categorical variables. Due to the large sample size,
differences may be significant but yet without practical
importance. For all significant associations we calculated
the effect size (Cohen’s w [43]) and included variables in
t h em u l t i v a r i a t em o d e l so n l yi ft h e yw e r es i g n i f i c a n t l y
associated to both exposure and outcome, and had at
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outcome. Logistic regression models (presented as odds
ratios with 95% confidence intervals) were used to inves-
tigate the strength of associations between anxiety/
depression/somatic symptoms and both the individual
gastrointestinal symptoms, as well as high GI com-
plaints. As we had exact information on the time
between the baseline measurements and outcome data,
we used Cox regression to estimate hazard ratios (with
95% confidence intervals) for later sickness absence
from GI complaints, adjusted for confounding. We pre-
dicted risk for the first occurrence of long term sickness
absence after the baseline health survey, while also tak-
ing into account length of this first period. In a hier-
archical fashion these models were then adjusted for
anxiety or depression, or experiencing a high load of
other somatic symptoms. Finally, we examined if there
were any additive interaction between GI complaints
and anxiety, depression or gender towards risk of LTSA.
All analyses, including identifying regression coefficients
for the interaction analyses, was done in STATA 11,
while the presence of additive interaction was examined
using the algorithm suggested by Andersson et.al [44],
w h e r eas y n e r g yi n d e x( S I )d e v i a t i n gf r o m“1” indicates
presence of an additive interaction [45].
Ethics
The study protocol was approved by the Regional Com-
mittee for Medical Research Ethics, Western Norway
and by the Norwegian Data Inspectorate.
Results
Higher levels of gastrointestinal complaints were
observed amongst females, those with lower levels of
education, the health risk behaviours of smoking, high
BMI, and low levels of physical activity, and amongst
those reporting physical illness, high physical symptom
load and case levels of anxiety and depression. Only the
associations with the last three variables were of suffi-
cient effect for inclusion in the further analyses (table
1). The same variables had similar associations with the
taking of at least one episode of sickness absence greater
than 16 days during follow up (LTSA), with female gen-
der, lower education and smoking being associated at
the level set for inclusion in further analyses, in addition
to high physical symptom load, anxiety and depression
(table 2). Age and the level of alcohol use were not asso-
ciated with either GI symptoms or LTSA.
Each of the individual GI symptoms was statistically
significantly associated with anxiety and depression,
with odds ratios ranging from 2.29 to 4.63 (table 3). The
strongest association was found between anxiety and
nausea (OR 4.63, 95% CI 3.38-6.34). While some of the
specific GI complaints were more strongly associated
with anxiety and depression than others, their respective
associations with anxiety and depression were similar
with overlapping confidence intervals. For each of the
specific GI-symptoms, the association with a general
high level of somatic symptom reporting was stronger
compared to that for anxiety and depression.
T h ep r e s e n c eo fh i g hl e v e l so fG Ic o m p l a i n t sw a s
associated with future LTSA (table 4). The overall risk
for any LTSA over follow up, adjusted for gender, edu-
cation and smoking was 1.42 (95% CI 1.34-1.51), and
1.17 (95% CI 1.10-1.16) in the fully adjusted model.
When comparing subgroups of LTSA defined by dura-
tion, the hazard ratios were higher with longer durations
of the first period of LTSA after the health screening,
although with overlapping confidence intervals: For
LTSA lasting 17-55 consecutive days, the gender, educa-
tion and smoking adjusted risk from GI complaints was
1.47 (95% CI 1.34-1.60), while the corresponding risk if
the first period lasted 90 days or more was 1.70 (95% CI
1.51-1.93). Individual further adjustment for depression
explained between 7 and 8% of the risk, while adjust-
ment for anxiety explained between 10 and 17% of the
risk. Adjustment for potential confounding of general
somatic symptom reporting on top of gender, education
and smoking explained a larger proportion of the risk:
between 32 and 48%. In the final model including all
covariates simultaneously, the risk was substantially atte-
nuated but still statistically significant at 1.19 (95% CI
1.08-1.32) for LTSA’s between 17-55 days and 1.33 (95%
CI 1.16-1.53) for 90 or more days (table 4).
With regard to specific GI complaints, stomach pain
had the strongest gender, education and smoking
adjusted association with LTSA (HR = 1.69, 95% CI
1.53-1.87). The variable “coated tongue” had the weakest
initial risk with HR = 1.35 (95% CI 1.23-1.48). After
adjustment for other symptoms, nausea and coated ton-
gue no longer incurred any independent risk of LTSA
(table 5).
Finally, we did not identify any significant additive
interactions between GI complaints and anxiety (SI =
1.10, 95% CI 0.84-1.42), depression (SI = 1.09, 95% CI
0.78-1.53), or gender (SI = 1.06, 95% CI 0.89-1.27), in
predicting LTSA.
Discussion
Main findings
In this large population based cohort study, people who
reported high levels of GI complaints were at increased
risk of long-term sickness absence (>16 days in the Nor-
wegian system) over up to 6 years later. As in previous
studies, there was a strong association between anxiety
and depression and a high level of GI complaints, parti-
cularly nausea. Despite this, anxiety and depression
explained relatively little of the increased risk for
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high level of other somatic symptoms explained com-
paratively more of the risk. These results were similar
for any one of the specific GI complaints.
Strength and weaknesses
The main strengths of this study lie in its prospective
nature, size, ability to adjust for multiple confounders,
and that measurement at baseline could not be biased
with regards to the aim of this study. Furthermore our
combined use of health study data and objective infor-
mation on sickness absences from public registries
reduces common method problems. The payment of
benefits requires correct registration and a personal
identification number, and for this reason the outcome
data are considered highly accurate. Only people leaving
Norway or dying would be excluded from follow up.
However the final participation rate with full data was
only 47%. Results from a recent study suggest that non-
participation in Norwegian population based health stu-
dies probably lead to underestimated prevalence esti-
mates, but that studies focusing on associations between
variables suffers less from health selection in non-parti-
cipation [46]. In addition non-participation is higher
amongst sicker people, those with mental disorder and
those with higher rates of LTSA. Thus our observations
would likely be an underestimate of any true association.
The measurement of GI symptoms was taken from a
somatisation assessment. This did not include any mea-
sure of duration of symptoms, unlike the Rome III cri-
teria for functional gastrointestinal disorders, which
separate the chronic and the fluctuating conditions. Our
lack of a duration criteria is a weakness as we are mod-
elling the associations with long-term outcomes that, if
indeed caused by the GI complaints, should be limited
to the chronic or recurrent cases. Again this weakness
should lead us to present underestimations of the true
association.
Table 1 Total sample characteristics and associations with levels of GI complaints at baseline*
Full
sample
GI complaints <80th
percentile
GI complaints >80th
percentile
n % n % n % difference Cohen’s w**
Total sample 13880 100 11245 81.0 2635 19.0
Age (mean/SD)*** 43.2 1.5 43.2 1.54 43.2 1.56 t(-1.4), df = 13878, p = 0.17 -
Gender c
2 = 74.9, df = 1, p < 0.001 0.07
Males 6694 48.2 5623 50.0 1071 40.7
Females 7186 51.8 5622 50.0 1564 59.4
Highest education level c
2 = 75.0, df = 2, p < 0.001 0.07
Elementary school 2226 16.2 1688 15.1 538 20.6
Upper secondary school 6367 46.2 5111 45.8 1256 48.0
Higher education 5189 37.7 4368 39.1 821 31.4
Physical illness 1010 7.3 741 6.6 269 10.2 c
2 = 41.7, df = 1, p < 0.001 0.05
BMI c
2 = 22.7, df = 2, p < 0.001 0.04
Normal (BMI < 25) 7083 51.1 5776 51.4 1307 49.7
Overweight (BMI 25-30) 5296 38.2 4322 38.5 974 37.0
Obese (BMI >30) 1491 10.8 1140 10.1 351 13.3
Smoking 4705 33.9 3658 32.5 1047 39.7 c
2 = 49.4, df = 1, p < 0.001 0.06
Alcohol use c
2 = 2.2, df = 3, p = 0.54 -
Abstainer 1027 7.6 828 7.5 199 7.7
Low consumption 4431 32.7 3577 32.5 854 33.1
Average consumption 4287 31.6 3504 31.9 783 30.4
High consumption 3823 28.2 3082 28.0 741 28.8
Physical activity c
2 = 30.8, df = 2, p < 0.001 0.04
No activity 2103 15.3 1629 14.6 474 18.2
Moderate 5622 40.8 4526 40.6 1096 42.0
High 6041 43.9 5002 44.8 1039 39.8
Anxiety 2281 16.4 1376 12.2 905 34.4 c
2 = 759.8, df = 1, p < 0.001 0.23
Depression 1186 8.5 718 6.4 468 17.8 c
2 = 353.5, df = 1, p < 0.001 0.16
Somatic symptoms 2375 17.1 1090 9.7 1285 48.8 c
2 = 2300.0, df = 1, p < 0.001 0.41
* For dichotomous variables we present numbers and rates for positive cases only
** Effect sizes calculated for significant univariate associations only
*** Continuous variable: presented with mean and standard deviations (SD) and test for differences with independent sample t-test.
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symptoms, including the GI symptoms, we have
employed missing substitutions using individual mean
substitution assuming “missing at random”.W ed i dn o t
go to any such steps for the GI items for this paper, as
this would inflate the correlations between the GI com-
plaints and other symptoms.
T h eh e a l t hs t u d yd i dn o ti n c l u d ea n yo ft h ec l i n i c a l
information required for excluding organic aetiology for
the GI complaints presented by the participants in the
present study. Other physical conditions, which are
adjusted for, and medications taken should in theory be
only partly related to GI complaints, as supported in
our initial univariate analysis on this association. This is
Table 2 Association of baseline characteristics with Long Term Sickness Absence (LTSA) over up to 6 years of follow
up*
No LTSA
during follow up
One or more period of LTSA
during follow up
n % n % difference Cohen’s w**
Total sample 7422 53.5 6458 46.5
Age (mean/SD)*** 43.1 1.54 43.2 1.55 t(-1.8), df = 13878, p = 0.08 -
Gender c
2 = 304.7, df = 1, p < 0.001 0.15
Males 4444 54.4 2250 39.4
Females 3722 45.6 3464 60.6
Highest education level c
2 = 265.2, df = 2, p < 0.001 0.14
Elementary school 1058 13.0 1168 20.6
Upper secondary school 3592 44.3 2775 49.0
Higher education 3465 42.7 1724 30.4
Physical illness 500 6.1 510 9.0 c
2 = 39.3, df = 1, p < 0.001 0.05
BMI c
2 = 26.4, df = 2, p < 0.001 0.04
Normal (BMI < 25) 4194 51.4 2889 50.6
Overweight (BMI 25-30) 3182 39.0 2114 37.0
Obese (BMI >30) 787 9.6 704 12.3
Smoking 2460 30.1 2245 39.3 c
2 = 126.0, df = 1, p < 0.001 0.10
Alcohol use c
2 = 17.3, df = 3, p = 0.54 -
Abstainer 578 7.2 449 8.1
Low consumption 2535 31.6 1896 34.1
Average consumption 2618 32.7 1669 30.0
High consumption 2281 27.5 1542 27.8
Physical activity c
2 = 32.2, df = 2, p < 0.001 0.05
No activity 1155 14.2 948 16.8
Moderate 3255 40.1 2367 41.9
High 3712 45.7 2329 41.3
Anxiety 1129 13.8 1152 20.2 c
2 = 98.3, df = 1, p < 0.001 0.08
Depression 591 7.2 595 10.4 c
2 = 43.4, df = 1, p < 0.001 0.06
Somatic symptoms 1019 12.5 1356 23.7 c
2 = 300.1, df = 1, p < 0.001 0.15
* For dichotomous variables we present numbers and rates for the positive cases only
** Effect sizes calculated for significant univariate associations only
*** Continuous variable: presented with mean and standard deviations (SD) and test for differences with independent sample t-test.
Table 3 Gender, education and smoking adjusted associations between the GI complaints individually and combined,
and anxiety, depression and other somatic symptoms
Nausea Stomach
pain
Feeling
bloated
Coated
tongue
Vomiting or
regurgitation
Frequent loose
bowel movements
GI complaints
(>80th percentile)
OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Anxiety 4.63 3.38-6.34 3.23 2.75-3.80 2.56 2.27-2.88 2.42 2.09-2.81 3.02 2.30-3.97 2.63 2.26-3.07 3.66 3.31-4.04
Depression 4.43 3.10-6.32 3.19 2.63-3.87 2.56 2.20-2.97 2.29 1.89-2.76 2.79 2.02-3.84 2.55 2.12-3.06 3.28 2.89-3.72
Somatic symptoms 7.20 5.19-9.99 4.75 4.04-5.56 4.14 3.70-4.64 4.60 4.00-5.30 4.93 3.78-6.44 3.80 3.28-4.42 8.50 7.69-9.40
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toms of underlying pathology. Below, we discuss the
relevance of this for clinical management.
Interpretation
The key finding in the present study was the increased
risk of LTSA during follow-up among those with a
higher level of GI complaints. The most parsimonious
interpretation of this is that these GI complaints are
symptoms or a marker for a range of underlying gastro-
intestinal pathologies. In this study, we had no capacity
to examine possible organic causes for these GI com-
plaints. At the same time, we know that much of the
time such complaints are not explained by positive find-
ings [5,6,15,47,48] and in a non-clinical sample of peo-
ple in their forties, functional complaints should be
more common than organic failure or pathology. Sup-
porting this are the observations that although nearly 14
000 individuals provided answers to the items of interest
for the present study, this is still only about 47% of the
approximately 29 000 eligible 40-47 year olds in the
county at the time of the health study. Those who did
not participate had poorer average health [49,50] and
more often received benefits [51].
Another explanation could be that that these symp-
toms are expressions of the most common causes of
long term sickness absence: depression and anxiety. Cer-
tainly we confirmed a strong association between GI
complaints and anxiety/depression. However adjusting
for these potential confounders did little to explain the
observed association. The overall measure of physical
symptom reporting was both highly associated with GI
complaints and LTSA and appeared to be a strong con-
founder. In this study relatively few participants (7.3%)
had a chronic physical illness, and only a few of these
illnesses in the list above would have resulted in GI
complaints. In some cases, these other somatic symp-
toms may well be followed by gastro-related organic fail-
ure. Adjusting for the other symptoms could reflect
overadjustment, leading us to underestimate the impact
of the GI complaints on sickness absence. This latter is
in line with Agreus’ study where those with GI com-
plaints had more sickness absence than the general
population, but their sickness absences were most often
warranted from non GI-related medical causes [20].
While this certainly is possible within such a large sam-
ple, several factors suggest this should not be a major
factor. The GI complaints were also abstracted from a
list of symptoms that in sum makes up the requirements
for somatisation disorder. Splitting these symptoms into
organ specificity, and then reintroducing the remaining
symptoms as adjustments, m a yb yd e f a u l ti n t r o d u c e
Table 4 Cox proportional hazard models assessing the association of high levels of GI symptom reporting with
subsequent long term sickness absence (LTSA) of various durations, with adjustments for individual potential
confounders and finally adjusting for all potential confounders
LTSA >16-55 consecutive days
(predicting 2763 LTSA’s)
LTSA >55-89 consecutive days
(predicting 1258 LTSA’s)
LTSA >89 consecutive days
(predicting 1340 LTSA’s)
Adjustments HR 95%CI HR 95%CI HR 95%CI
Crude 1.59 1.46-1.74 1.72 1.51-1.96 1.91 1.69-2.16
Model 1: Gender, education and smoking 1.47 1.34-1.60 1.55 1.36-1.77 1.70 1.51-1.93
Model 1 + depression 1.43 1.31-1.57 1.50 1.31-1.71 1.63 1.44-1.85
Model 1 + anxiety 1.40 1.27-1.53 1.48 1.29-1.70 1.61 1.42-1.83
Model 1 + somatic symptoms 1.22 1.10-1.34 1.35 1.17-1.56 1.38 1.20-1.58
Full adjustment* 1.19 1.08-1.32 1.31 1.13-1.52 1.33 1.16-1.53
* Adjusted for gender, education, smoking, depression, anxiety and somatic symptoms.
Table 5 Cox proportional hazard models assessing the association of high levels of GI symptom reporting with any
subsequent long term sickness absence (LTSA) with adjustments for individual potential confounders and finally
adjusting for all potential confounders
Nausea Stomach
pain
Feeling
bloated
Coated
tongue
Vomiting or
regurgitation
Frequent loose
bowel
movements
HR 95%CI HR 95%CI HR 95%CI HR 95%CI HR 95% CI HR 95%CI
Crude 1.65 1.34-2.02 1.69 1.53-1.87 1.51 1.41-1.63 1.35 1.23-1.48 1.60 1.35-1.90 1.38 1.25-1.52
Adjusted for gender, education and smoking 1.42 1.16-1.75 1.57 1.42-1.74 1.38 1.28-1.49 1.27 1.16-1.40 1.59 1.34-1.89 1.42 1.29-1.57
Anxiety* 1.28 1.05-1.58 1.46 1.32-1.62 1.32 1.22-1.42 1.21 1.10-1.33 1.47 1.23-1.75 1.34 1.22-1.48
Depression* 1.33 1.08-1.63 1.51 1.36-1.67 1.34 1.25-1.44 1.24 1.13-1.37 1.51 1.27-1.80 1.37 1.24-1.51
Somatic symptoms* 1.14 0.93-1.40 1.35 1.21-1.49 1.21 1.12-1.31 1.09 0.98-1.20 1.34 1.13-1.60 1.25 1.13-1.38
* Adjusted for the health variable on top of gender, education and smoking.
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Page 7 of 10over-adjustment of associations. Taken together, these
findings could indicate that although GI complaints are
related to anxiety and depression, the functional out-
comes from GI complaints in terms of sickness absence
are possibly due in large part to GI complaints being
part of a person’s tendency to experience and/or report
symptoms across the various organ systems. This
hypothesis is supported by a previous paper from this
cohort showing that high levels of health anxiety was a
strong predictor of leaving the workforce entirely and
moving onto a disability pension [52].
The discrepancy between “explained” and “unex-
plained” or “functional” gastrointestinal conditions is
blurred and changing with new developments in e.g.
understanding of pain and neuropathology. For some
psychosocial outcomes the distinction may be less rele-
vant: A recent study by Kisely and colleagues [53] found
that the difference in functional outcomes between
explained and unexplained symptoms were rather small.
In addition, there seems to be a relatively low corre-
spondence between organic findings and the degree of
suffering from the symptoms [54,55]. Finally, welfare
schemes influence access to sickness absences, and the
Norwegian system is known as relatively generous. Still,
studies from US populations also suggest GI complaints
are associated with occupational consequences [1,22],
and the associations between GI complaints, other
symptoms and mental illnesses, is consistent in the
international literature. Our main finding of an indepen-
dent effect of GI complaints should therefore also be
informative beyond a Norwegian context.
Conclusions
A high level of gastrointestinal complaints predicts
objectively ascertained long term sickness absences. This
was consistent across varying definitions of long term
sickness absence. Our results confirmed the close rela-
tionships between GI complaints, depression and anxi-
ety, but at the same time this did not seem to explain
the work related functional outcomes of GI complaints.
T h ep r e s e n c eo fo t h e rs o m a t i cs y m p t o m ss e e m sm o r e
important in understanding functional outcomes of GI
complaints, lending support to theories of commonal-
ities across symptom representations. Future work using
more advanced latent class and path analytic techniques
will help our understanding of how these symptom pat-
terns combine and contribute to complex behaviours
such as sickness absence.
For clinicians our results would suggest that manage-
ment of the investigation and treatment of any underly-
ing pathology in those with GI complaints should
continue to be augmented by helping the individual
manage their behaviour and disability. This is not just a
focus on identifying and treating comorbid psychological
illness, which is important, but would involve a nuanced
understanding of individual’s beliefs about their symp-
toms, the causes and implications. Identifying maladap-
tive behavioural responses to GI symptoms may help
people improve their psychosocial outcomes. In this
respect the work concerning illness perceptions, and
demonstrations that tackling these can improve work
related outcomes [56] may prove fruitful for clinicians
and rehabilitation providers. Finally, our data do not
pinpoint which aspects of GI complaints lead to long
term absence from work. It could be the activity limita-
tions associated with symptoms such as pain, or that,
anecdotally, people often take time off work whilst they
are being investigated. Beliefs that work somehow con-
tributes to or perpetuates these symptoms, or may be a
cause of a disease, can also contribute to people wanting
sickness absence. It may even be that common factors
such as early childhood experiences can explain the
association [57,58]. Future clinical studies could benefit
from including sickness absence as an outcome of inter-
est, as it is an outcome of high societal and individual
relevance, and help identify which aspects of gastroin-
testinal conditions lead to these poorer sequelae.
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